A customized approach to your most complex challenges
As increasing regulatory and scientific complexities threaten R&D productivity, you need a bioanalytical and ADME partner with scientific competence, regulatory expertise and capacity to meet demanding timelines via customized solutions.
Enhance your programs with streamlined solutions
Quintiles offers a complete laboratory solution for testing across the development spectrum through the collective services provided by our global early clinical, central labs, and bioanalytical and ADME labs network. The result is timely, high-quality, regulatory compliant data that supply the insights you need to make more informed decisions and instill confidence in your regulatory filings.
Our bioanalytical and ADME services include:
- Bioanalytical LC/MS/MS services. Assisting in the quantitative determination of small molecule drugs, biologics and biosimilars in support of pharmacokinetic (PK) studies.
- In vitro ADME and metabolite identification services. Supporting drug discovery and ADME regulatory filings.
- Immunoassay services. Providing ELISA, electrochemiluminescence (ECL) and neutralizing antibody (NAB) assays in support of biologic and biosimilar PK and immunogenicity studies.
- Biomarker services. Offering LC/MS and ligand-binding assays for the quantitative determination of bioanalytical biomarkers.
Quintiles is recognized for scientific excellence, an exemplary regulatory track record and uncompromised quality, serving many of the largest pharmaceutical, specialty pharmaceutical and biotechnology companies.